Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

Understanding How Clinical HPV Testing Leads to Personalized Medicine At Its Best


Human papillomaviruses (HPVs) are the etiologic agents for a significant fraction of many cancers in humans. Our understanding of the pathogenesis of these tumors has led to almost continuous refinement in our approach to managing patients at risk for these tumors. These refinements include improved testing strategies for both screening, triage, diagnosis and treatment. This presentation will update you on how our current understanding of HPV biology and testing provides our patients with medical care personalized to their biology and risk.

Learning Objectives:

  1. Briefly review the biology of HPV in carcinogenesis.
  2. Describe the importance of clinically valid HPV testing in modern cervical cancer screening paradigms.
  3. Appreciate the clinical utility of HPV-related IHC and/or ISH in making a correct histologic diagnosis on cervical specimens.

Leica Biosystems webinars, training presentations and related materials provide general information regarding particular subjects and are not intended to be, and should not be construed as medical, regulatory or legal advice. The views and opinions expressed are the personal views and opinions of the speaker(s)/author(s) and do not necessarily represent or reflect the views or opinions of Leica Biosystems, its employees or agents.

For the use of any product, the product information guides, inserts and operation manuals of the various products and devices should be consulted. Leica Biosystems and the editors disclaim any liability arising directly or indirectly from the use of devices, techniques or procedures described in these materials.

Copyright © 2017 by Leica Biosystems Richmond Inc. All rights reserved.LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.